BYND

Business Context and Reporting Period

Company: BEYOND MEAT, INC. (BYND)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended September 28, 2024 (Q3 2024)
Business Overview: Beyond Meat is a leading plant-based meat company offering beef, pork, and poultry platforms. The company is currently executing a "Global Operations Review" initiated in November 2023 to narrow commercial focus, reduce operating expenses, and prioritize gross margin expansion and cash generation. This includes workforce reductions, discontinuation of select product lines (e.g., Beyond Meat Jerky), and a review of operations in China.

Key Financial Metrics

Note: Cash flow from operating activities for the nine months ended Sept 28, 2024, was a net use of $69.9 million.

Material Changes vs. Prior Period

• Revenue Growth (Q3): Net revenues increased 7.6% year-over-year to $81.0 million, driven by a 15.8% increase in net revenue per pound (due to price increases and lower trade discounts), partially offset by a 7.1% decrease in volume.
• Margin Improvement: Gross margin improved significantly to 17.7% in Q3 2024 from a negative 9.6% in Q3 2023. This was driven by lower cost of goods sold per pound (reduced inventory provision, logistics, and materials costs) and higher net revenue per pound.
• Expense Reduction: Operating expenses decreased significantly. SG&A expenses dropped 26.6% in Q3 and 15.8% YTD, primarily due to lower salaries, bad debt expense, and consulting fees. R&D expenses decreased 32.7% in Q3 due to headcount reductions.
• Volume Decline (YTD): For the nine months ended Sept 28, 2024, total volume of products sold decreased 12.6% year-over-year, reflecting weak category demand.
• International Foodservice: International foodservice revenues declined 17.2% in Q3 and 15.7% YTD, largely due to decreased sales to a large QSR customer in the EU.

Guidance, Outlook, Risks, and Unusual Items

• Liquidity Outlook: Management believes existing cash balances and anticipated cash flow will fund operations for the next 12 months. However, the company expects to continue operating at a loss and anticipates needing to raise significant additional capital in 2024 and 2025 via equity or debt, which may result in dilution.
• ATM Program: The company has an "at-the-market" equity distribution agreement with Goldman Sachs for up to $200 million. No sales have been made under this program as of Sept 28, 2024. A new agreement with B. Riley Securities is anticipated.
• Unusual Items:
  • Class Action Settlement: The company recorded $7.5 million in SG&A expenses related to a settlement of consumer class action lawsuits regarding protein claims. $250,000 was paid in Q3, with the remainder accrued and expected to be paid in 2025 pending court approval.
  • Foreign Currency: Q3 included a $4.1 million net gain from foreign currency transactions, while YTD included a $0.6 million gain.
• Key Risks:
  • China Operations: Continued review of operations in China, which may lead to scaling back or discontinuation, potentially resulting in impairment charges and write-offs.
  • Regulatory/Litigation: Ongoing litigation regarding the use of "meat" terminology in the EU (France) and US. The CJEU recently ruled the French ban on meat names for plant-based foods unlawful, but the case reverts to the French High Administrative Court.
  • Debt: Significant indebtedness ($1.15 billion principal in Convertible Senior Notes due 2027) limits cash flow flexibility and requires future refinancing or repayment.
  • Inventory: Risks related to managing inventory levels, including potential write-downs or sales to liquidation channels.

Investor Verification Checklist

• Cash Runway: Verify the sufficiency of the $134.9 million total cash position (unrestricted + restricted) against the projected burn rate and the timeline for raising additional capital.
• Settlement Finality: Confirm the final court approval status of the $7.5 million consumer class action settlement and the timing of the remaining payment.
• China Strategy: Monitor announcements regarding the final decision on China operations, as discontinuation could trigger significant non-cash impairment charges.
• Volume vs. Price: Assess whether the recent revenue growth driven by price increases can be sustained without further volume erosion in a competitive market.
• Debt Refinancing: Evaluate the company's ability to refinance or repay the $1.15 billion Convertible Senior Notes maturing in 2027 given current market conditions and stock price volatility.